Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogeneic MSCs for Post-Transplant Cytopenias
NCT02104440Phase 2Completed
- Sponsor
- Red de Terapia Celular
- Start
- Oct 2013
- Primary completion
- Mar 2017
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of MSV alogénicas in cytopenia, sponsored by Red de Terapia Celular. Started Oct 2013; status: completed.
02
Drugs
MSV alogénicas
03
Conditions
cytopenia
Beyond the preview
Go deeper on NCT02104440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02104440.